AgeX Therapeutics, Inc. (AGE)

Cash & Equivalents

$23.02M

Quarterly · Period ending: · USD

AGE logo

AGE Cash & Equivalents

Latest reported$23.02M
AGE Quarterly Cash & Equivalents ($11.36M → $23.02M)
High-resolution chart · PNG

AGE cash & equivalents history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

AgeX Therapeutics, Inc. Cash & Equivalents — Quarterly (USD)
Period endingCash & Equivalents (USD)
23,024,000
24,526,000
3,056,000
8,620,000
6,041,000
4,267,000
3,672,000
3,185,000
6,064,000
8,706,000
345,000
397,000
261,000
280,000
645,000
466,000
702,000
448,000
584,000
731,000
615,000
809,000
527,000
1,107,000
1,033,000
468,000
2,352,000
3,768,000
5,813,000
8,586,000
6,707,000
8,756,000
11,360,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.